Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

PNNL is working with the Port of Seattle and Seattle City Light to assess the risks of long-term hydrogen storage that can bring clean power for decarbonization.

Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Harnessing the sea for decarbonized energy is the focus of a new collaboration between PNNL and the University of Guam.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

Research published in Journal of Manufacturing Processes demonstrates innovative single-step method to manufacture oxide dispersion strengthened copper materials from powder.

A PNNL team developed and used a model framework to understand the performance and structural reliability of a state-of-the-art solid oxide electrolysis cell design.

Multidisciplinary teams from research and industry are brought together using management systems developed by a team of software engineers at PNNL.

Silicone wristbands could be more convenient option for collecting exposure data.

Tailoring hydrogen-based energy storage solutions to specific real-world applications.

A process developed at PNNL that converts biomass and waste into a chemical intermediate or into gasoline, diesel, and jet fuel is available for commercial licensing.

The Co-Optimization of Fuels & Engines initiative recently outlined six years of research in a findings and impact report.

Scientists from PNNL and the U.S. Department of Agriculture-Forest Services’ Pacific Northwest Research Station have partnered to evaluate potential climate and wildfire adaptation scenarios and resulting benefits from restoration forestry.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

Hypergraphs can more faithfully identify important genes in complex immune responses.

The web-based tool, called PLATIPUS, is publicly available and interacts with publications available in the CovidScholar database.